EVM14 received U.S. FDA clearance for its IND application, becoming Everest's first internally discovered program, and the first mRNA therapeutic cancer vaccine to be cleared for global clinical ...

Lawyers inside and outside the US Securities and Exchange Commission (SEC) have speculated that the agency’s new leadership will take a ...

Patients hoping for a kidney transplant must first undergo a battery of medical tests to determine whether they are suitable candidates for the ...

The evolution of the safety and effectiveness evaluation of endovascular grafts intended for abdominal aortic aneurysm repair ...

Finally, the widespread deployment of AI will catalyze change in almost every aspect of healthcare, including using AI to ...

Qube Integrated Malaysia Sdn. Bhd., the organiser of SEACare 2025, is proud to announce the inaugural SEA Healthcare and Pharma Conference ...

Or, MD, a distinguished researcher and neurologist at Penn Medicine, is the winner of the 2025 John Dystel Prize for Multiple ...

Billions of clinical insights—once buried in an unusable format—may now be used to train large language models and inform clinical research studies.

VBP301, a Phase 1/2, multicenter, open-label, first-in-human study of VCAR33, is a transplant donor-derived anti-CD33 CAR-T ...

Pharos iBio announced on the 21st that it has signed a memorandum of understanding (MOU) for the development of companion ...

VCAR33 clinical data update planned for first half of 2025 and trem-cel + Mylotarg clinical data update planned for second half of 2025 Anticipate initiation of the first trem-cel+VCAR33 Treatment Sys ...

The demand for senior care services is poised for intense growth in the next 10 years as the Baby Boomer generation enters retirement. | Health tech company Inspiren developed intelligent AI-powered ...